药品注册申请号:011790
申请类型:NDA (新药申请)
申请人:HIKMA
申请人全名:HIKMA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ROBAXIN METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Yes Yes AP 1959/06/10 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2014/08/12 SUPPL-51(补充) Approval Manufacturing (CMC) STANDARD
2014/04/29 SUPPL-50(补充) Approval Manufacturing (CMC) STANDARD
2004/05/04 SUPPL-46(补充) Approval Labeling STANDARD
2001/02/28 SUPPL-42(补充) Approval Manufacturing (CMC) STANDARD
1999/12/29 SUPPL-41(补充) Approval Manufacturing (CMC) STANDARD
1998/04/22 SUPPL-40(补充) Approval Manufacturing (CMC) STANDARD
1990/12/11 SUPPL-38(补充) Approval Manufacturing (CMC) STANDARD
1988/12/02 SUPPL-37(补充) Approval Manufacturing (CMC) STANDARD
1987/01/22 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
1987/01/07 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1986/01/03 SUPPL-34(补充) Approval Manufacturing (CMC) STANDARD
1983/06/20 SUPPL-32(补充) Approval Labeling
1982/12/16 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
1982/09/03 SUPPL-30(补充) Approval Manufacturing (CMC) STANDARD
1982/01/22 SUPPL-28(补充) Approval Labeling
1981/09/29 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1981/06/10 SUPPL-27(补充) Approval Labeling
1980/05/23 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1980/05/23 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1980/05/01 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1980/01/03 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1979/09/17 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1976/03/11 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1959/06/10 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:METHOCARBAMOL 剂型/给药途径:SOLUTION;IM-IV 规格:1GM/10ML (100MG/ML) 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011790 001 NDA ROBAXIN METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription Yes Yes AP Approved Prior to Jan 1, 1982 HIKMA
204404 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Discontinued No No AP 2014/12/05 MYLAN INSTITUTIONAL
206128 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2016/05/27 EUGIA PHARMA
205354 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2016/10/27 MONTEREY PHARMS LLC
208116 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2017/01/19 SLATE RUN PHARMA
207496 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2017/06/22 AM REGENT
205404 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2017/07/18 SAGENT PHARMS INC
207522 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2017/07/31 SOMERSET THERAPS LLC
206071 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2017/11/24 NAVINTA LLC
209331 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2018/04/17 FRESENIUS KABI USA
211504 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Prescription No No AP 2018/10/26 GLAND PHARMA LTD
215065 001 ANDA METHOCARBAMOL METHOCARBAMOL SOLUTION;IM-IV 1GM/10ML (100MG/ML) Discontinued No No AP 2022/07/14 BAXTER HLTHCARE CORP
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database